| Abdallah Halim El-habr, | |
|
1235 Old York Rd Ste G121, Abington, PA 19001-3800 | |
| (215) 517-1200 | |
| Not Available |
| Full Name | Abdallah Halim El-habr |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 33 Years |
| Location | 1235 Old York Rd Ste G121, Abington, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689767915 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Abington Memorial Hospital | Abington, PA | Hospital |
| Abington Health Lansdale Hospital | Lansdale, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Abington Memorial Hospital | 3274437736 | 528 |
| Amh Medical Staff Service Fund | 9830003813 | 42 |
News Archive
As government, industry and academic leaders work to transform the nation's health information system, there is increasing interest in the notion of a national health information network in which consumers can actively engage, and which can provide the foundation for an "iPhone-like" ecosystem of applications to compete on price and value.
When treated with stereotactic radiosurgery, that is not combined with whole brain radiotherapy, adult brain cancer patients who were 50 years old and younger were found to have improved survival, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.
Sitting down on the job has its advantages. New data from The University of Kansas Hospital finds that patients perceive doctors who sit down during their hospital room visits stay longer than doctors who stand during the visit – even when doctors who sit don't stay as long as doctors who stand.
Researchers at the University of Iowa have discovered a new cause of hydrocephalus, a devastating neurological disorder that affects between one and three of every 1,000 babies born. Working in mice, the researchers identified a cell signaling defect, which disrupts immature brain cells involved in normal brain development.
Merck Sharp & Dohme Ltd. MSD (known as Merck & Co., Inc. in the United States and Canada), today announced the presentation of results from a Phase 2b clinical trial evaluating the safety and efficacy of once daily oral doravirine, an investigational next-generation non-nucleoside reverse transcriptase inhibitor (NNRTI), plus tenofovir/emtricitabine (TDF/FTC) compared to efavirenz plus TDF/FTC in previously untreated patients with HIV-1 infection.
› Verified 4 days ago
| Entity Name | Amh Medical Staff Service Fund |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356384457 PECOS PAC ID: 9830003813 Enrollment ID: O20031114000011 |
News Archive
As government, industry and academic leaders work to transform the nation's health information system, there is increasing interest in the notion of a national health information network in which consumers can actively engage, and which can provide the foundation for an "iPhone-like" ecosystem of applications to compete on price and value.
When treated with stereotactic radiosurgery, that is not combined with whole brain radiotherapy, adult brain cancer patients who were 50 years old and younger were found to have improved survival, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.
Sitting down on the job has its advantages. New data from The University of Kansas Hospital finds that patients perceive doctors who sit down during their hospital room visits stay longer than doctors who stand during the visit – even when doctors who sit don't stay as long as doctors who stand.
Researchers at the University of Iowa have discovered a new cause of hydrocephalus, a devastating neurological disorder that affects between one and three of every 1,000 babies born. Working in mice, the researchers identified a cell signaling defect, which disrupts immature brain cells involved in normal brain development.
Merck Sharp & Dohme Ltd. MSD (known as Merck & Co., Inc. in the United States and Canada), today announced the presentation of results from a Phase 2b clinical trial evaluating the safety and efficacy of once daily oral doravirine, an investigational next-generation non-nucleoside reverse transcriptase inhibitor (NNRTI), plus tenofovir/emtricitabine (TDF/FTC) compared to efavirenz plus TDF/FTC in previously untreated patients with HIV-1 infection.
› Verified 4 days ago
| Entity Name | Abington Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891749685 PECOS PAC ID: 3274437736 Enrollment ID: O20040114000442 |
News Archive
As government, industry and academic leaders work to transform the nation's health information system, there is increasing interest in the notion of a national health information network in which consumers can actively engage, and which can provide the foundation for an "iPhone-like" ecosystem of applications to compete on price and value.
When treated with stereotactic radiosurgery, that is not combined with whole brain radiotherapy, adult brain cancer patients who were 50 years old and younger were found to have improved survival, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.
Sitting down on the job has its advantages. New data from The University of Kansas Hospital finds that patients perceive doctors who sit down during their hospital room visits stay longer than doctors who stand during the visit – even when doctors who sit don't stay as long as doctors who stand.
Researchers at the University of Iowa have discovered a new cause of hydrocephalus, a devastating neurological disorder that affects between one and three of every 1,000 babies born. Working in mice, the researchers identified a cell signaling defect, which disrupts immature brain cells involved in normal brain development.
Merck Sharp & Dohme Ltd. MSD (known as Merck & Co., Inc. in the United States and Canada), today announced the presentation of results from a Phase 2b clinical trial evaluating the safety and efficacy of once daily oral doravirine, an investigational next-generation non-nucleoside reverse transcriptase inhibitor (NNRTI), plus tenofovir/emtricitabine (TDF/FTC) compared to efavirenz plus TDF/FTC in previously untreated patients with HIV-1 infection.
› Verified 4 days ago
| Entity Name | Critical Care Physicians Of Pennsylvania Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952670085 PECOS PAC ID: 2466610498 Enrollment ID: O20120222000844 |
News Archive
As government, industry and academic leaders work to transform the nation's health information system, there is increasing interest in the notion of a national health information network in which consumers can actively engage, and which can provide the foundation for an "iPhone-like" ecosystem of applications to compete on price and value.
When treated with stereotactic radiosurgery, that is not combined with whole brain radiotherapy, adult brain cancer patients who were 50 years old and younger were found to have improved survival, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.
Sitting down on the job has its advantages. New data from The University of Kansas Hospital finds that patients perceive doctors who sit down during their hospital room visits stay longer than doctors who stand during the visit – even when doctors who sit don't stay as long as doctors who stand.
Researchers at the University of Iowa have discovered a new cause of hydrocephalus, a devastating neurological disorder that affects between one and three of every 1,000 babies born. Working in mice, the researchers identified a cell signaling defect, which disrupts immature brain cells involved in normal brain development.
Merck Sharp & Dohme Ltd. MSD (known as Merck & Co., Inc. in the United States and Canada), today announced the presentation of results from a Phase 2b clinical trial evaluating the safety and efficacy of once daily oral doravirine, an investigational next-generation non-nucleoside reverse transcriptase inhibitor (NNRTI), plus tenofovir/emtricitabine (TDF/FTC) compared to efavirenz plus TDF/FTC in previously untreated patients with HIV-1 infection.
› Verified 4 days ago
| Entity Name | Abington Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487028262 PECOS PAC ID: 3274437736 Enrollment ID: O20160125000133 |
News Archive
As government, industry and academic leaders work to transform the nation's health information system, there is increasing interest in the notion of a national health information network in which consumers can actively engage, and which can provide the foundation for an "iPhone-like" ecosystem of applications to compete on price and value.
When treated with stereotactic radiosurgery, that is not combined with whole brain radiotherapy, adult brain cancer patients who were 50 years old and younger were found to have improved survival, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.
Sitting down on the job has its advantages. New data from The University of Kansas Hospital finds that patients perceive doctors who sit down during their hospital room visits stay longer than doctors who stand during the visit – even when doctors who sit don't stay as long as doctors who stand.
Researchers at the University of Iowa have discovered a new cause of hydrocephalus, a devastating neurological disorder that affects between one and three of every 1,000 babies born. Working in mice, the researchers identified a cell signaling defect, which disrupts immature brain cells involved in normal brain development.
Merck Sharp & Dohme Ltd. MSD (known as Merck & Co., Inc. in the United States and Canada), today announced the presentation of results from a Phase 2b clinical trial evaluating the safety and efficacy of once daily oral doravirine, an investigational next-generation non-nucleoside reverse transcriptase inhibitor (NNRTI), plus tenofovir/emtricitabine (TDF/FTC) compared to efavirenz plus TDF/FTC in previously untreated patients with HIV-1 infection.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Abdallah Halim El-habr, 2500 Maryland Rd Ste 400, Willow Grove, PA 19090-1225 Ph: (215) 481-4143 | Abdallah Halim El-habr, 1235 Old York Rd Ste G121, Abington, PA 19001-3800 Ph: (215) 517-1200 |
News Archive
As government, industry and academic leaders work to transform the nation's health information system, there is increasing interest in the notion of a national health information network in which consumers can actively engage, and which can provide the foundation for an "iPhone-like" ecosystem of applications to compete on price and value.
When treated with stereotactic radiosurgery, that is not combined with whole brain radiotherapy, adult brain cancer patients who were 50 years old and younger were found to have improved survival, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.
Sitting down on the job has its advantages. New data from The University of Kansas Hospital finds that patients perceive doctors who sit down during their hospital room visits stay longer than doctors who stand during the visit – even when doctors who sit don't stay as long as doctors who stand.
Researchers at the University of Iowa have discovered a new cause of hydrocephalus, a devastating neurological disorder that affects between one and three of every 1,000 babies born. Working in mice, the researchers identified a cell signaling defect, which disrupts immature brain cells involved in normal brain development.
Merck Sharp & Dohme Ltd. MSD (known as Merck & Co., Inc. in the United States and Canada), today announced the presentation of results from a Phase 2b clinical trial evaluating the safety and efficacy of once daily oral doravirine, an investigational next-generation non-nucleoside reverse transcriptase inhibitor (NNRTI), plus tenofovir/emtricitabine (TDF/FTC) compared to efavirenz plus TDF/FTC in previously untreated patients with HIV-1 infection.
› Verified 4 days ago
Dr. Shaili Nepal, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2191 Fax: 215-481-3411 | |
Muhammad Arslan Asghar Cheema, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2222 Fax: 215-481-4361 | |
Margaret Mack, Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2000 | |
Joseph Guererri Crocetti Jr., DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1235 Old York Rd, Ste 121, Abington, PA 19001 Phone: 215-517-1200 Fax: 215-517-1219 | |
Dr. Joseph Mcallister, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1235 Old York Rd, Ste 113, Abington, PA 19001 Phone: 215-517-1180 | |
William L. Ward, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1235 Old York Rd, Suite 121, Abington, PA 19001 Phone: 215-517-1200 Fax: 215-517-1219 | |
Rebecca Jane Fallis, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1235 Old York Rd Ste 220, Abington, PA 19001 Phone: 215-481-6350 Fax: 215-481-4237 |